在DNA损伤和免疫学标记方面,吸入麻醉剂之间的比较
Mariana G Braz1, Mariane A P Silva1, Carlos E Scorza1
1Universidade Estadual Paulista (UNESP), Faculdade de Medicina, Botucatu, Brazil.
Environmental and molecular mutagenesis
|April 29, 2024
概括
异黄和黄麻醉剂都没有在手术患者中引起遗传损伤. 这两种麻醉剂都增加了互白素-6 (IL-6) 水平,在异氨酸后观察到的增加更大.
科学领域:
- 麻醉学 麻醉学
- 免疫学 免疫学 免疫学
- 基因毒理学 基因毒理学
背景情况:
- 吸入麻醉剂如异氨酸和氨酸在手术中被广泛使用.
- 评估它们对遗传损伤和免疫反应的潜在影响对于患者安全至关重要.
- 之前的研究在这些药物的免疫调节作用方面产生了不同的结果.
研究的目的:
- 为了比较异黄素和黄素对手术患者DNA损伤和免疫标记物的影响.
- 为了确定这些麻醉剂是否构成基因毒性风险.
- 为了评估炎症前兆标记和白细胞计数在麻醉后的变化.
主要方法:
- 从在基线和麻醉后接受异黄素 (n=18) 或血黄素 (n=17) 麻醉手术的患者收集了血液样本.
- 通过性彗星测定来评估DNA损伤.
- 干白素-6 (IL-6) 水平和白细胞计数分别通过流细胞计和血液学分析进行测量.
主要成果:
- 在异黄素或异黄素组中没有检测到显著的DNA损伤.
- 在麻醉后的两组中都观察到轻度中性恋.
- 在麻醉后一天,两组人群中interleukin-6 (IL-6) 的水平都增加了,在异黄素组中更明显的升高.
结论:
- 在接受低压力手术的健康成年患者中,异黄和异黄麻醉并没有诱导基因毒性.
- 这两种麻醉剂都能改变免疫参数,特别是增加IL-6水平.
- 随着异黄后IL-6的较大增加,与sevoflurane相比,需要进一步调查其免疫调节特征.
更多相关视频
08:18Application of Laser Micro-irradiation for Examination of Single and Double Strand Break Repair in Mammalian Cells
Published on: September 5, 2017
9.8K
11:24Measuring DNA Damage and Repair in Mouse Splenocytes After Chronic In Vivo Exposure to Very Low Doses of Beta- and Gamma-Radiation
Published on: July 3, 2015
11.1K
相关概念视频
Inhalational Anesthetics: Overview
268
Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
268
Mutagenicity and Carcinogenicity
1.2K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.2K
